OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
BLAJ55

Balaji Phosphates Ltd

Commodity ChemicalsVerified

Balaji Phosphates Ltd has a fully diluted share count of 23,777,100 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is currently unavailable, limiting the ability to assess key financial ratios such as price-to-book or price-to-earnings. The company's profitability and return metrics are not available in the current dataset, making it difficult to compare its performance against industry_config preferred metrics or cohort medians. Without access to profitability data, it is not possible to evaluate whether the company is generating returns in line with or above industry benchmarks. Segment and geographic exposure data are not disclosed in the available source documents, preventing an assessment of revenue concentration or geographic diversification. This lack of transparency limits the ability to evaluate the company's exposure to regional economic or regulatory risks. Growth trajectory data is also unavailable, as the outlook for the current and next fiscal years, along with numeric deltas, are not provided. Without historical revenue data or forward-looking guidance, it is not possible to determine the company's growth potential or trajectory. Risk factors include the inability to assess liquidity risk due to missing balance-sheet inputs and the absence of going-concern language in source documents. The dilution potential is currently low, as there is no difference between basic and diluted shares outstanding. However, the lack of valuation and financial data limits the ability to fully assess the company's risk profile. Recent events, including filings and transcripts, are not disclosed in the available source documents, preventing an analysis of the company's recent strategic or operational developments.

30-day price · BLAJ-8.55 (-8.0%)
Low$98.00High$114.00Close$98.45As of21 May, 00:00 UTC
Profile
CompanyBalaji Phosphates Ltd
TickerBLAJ.NS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Balaji Phosphates Ltd is a chemical manufacturing company that produces and sells phosphate-based products, primarily serving the agriculture and industrial sectors.

Classification. Balaji Phosphates Ltd is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Balaji Phosphates Ltd has a fully diluted share count of 23,777,100 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's valuation snapshot is currently unavailable, limiting the ability to assess key financial ratios such as price-to-book or price-to-earnings. The company's profitability and return metrics are not available in the current dataset, making it difficult to compare its performance against industry_config preferred metrics or cohort medians. Without access to profitability data, it is not possible to evaluate whether the company is generating returns in line with or above industry benchmarks. Segment and geographic exposure data are not disclosed in the available source documents, preventing an assessment of revenue concentration or geographic diversification. This lack of transparency limits the ability to evaluate the company's exposure to regional economic or regulatory risks. Growth trajectory data is also unavailable, as the outlook for the current and next fiscal years, along with numeric deltas, are not provided. Without historical revenue data or forward-looking guidance, it is not possible to determine the company's growth potential or trajectory. Risk factors include the inability to assess liquidity risk due to missing balance-sheet inputs and the absence of going-concern language in source documents. The dilution potential is currently low, as there is no difference between basic and diluted shares outstanding. However, the lack of valuation and financial data limits the ability to fully assess the company's risk profile. Recent events, including filings and transcripts, are not disclosed in the available source documents, preventing an analysis of the company's recent strategic or operational developments.
Key takeaways
  • Balaji Phosphates Ltd has no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities.
  • Liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents.
  • Profitability and return metrics are not available, limiting the ability to compare the company's performance against industry benchmarks.
  • Segment and geographic exposure data are not disclosed, preventing an assessment of revenue concentration or geographic diversification.
  • Growth trajectory data is unavailable, as the outlook for the current and next fiscal years, along with numeric deltas, are not provided.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$731.1M$33.8M$11.1M$14.7M
FY-3$1.24B$70.2M$31.9M$36.7M
FY-2$1.45B$109.8M$60.9M$68.2M
FY-1$1.52B$112.8M$60.4M$60.0M
FY0$1.27B$123.2M$79.2M$50.8M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$691.9M$201.0M
FY-3$823.5M$228.6M$5.5M
FY-2$968.3M$289.6M$6.4M
FY-1$884.8M$350.0M$0.00
FY0$1.24B$800.4M$11.1M
PeriodOCFCapExFCFSBC
FY-4$78.7M-$6.4M$14.7M
FY-3$33.9M-$5.0M$36.7M
FY-2-$36.3M-$1.1M$68.2M
FY-1-$34.8M-$8.8M$60.0M
FY0-$364.4M-$37.9M$50.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
MetricBLAJActivity
Op margin5.5% medp25 -0.0% · p75 10.8%
Net margin4.1% medp25 0.1% · p75 8.8%
Gross margin20.5% medp25 12.4% · p75 29.7%
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-6.2% medp25 -13.4% · p75 -2.6%
Debt / equity37.1% medp25 10.3% · p75 82.0%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-08 01:35 UTC#7552575b
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 12:41 UTCJob: 6a8cb52d